世界の注射用オマリズマブ市場2021-2026:注射用皮下粉末、皮下液(150mg / mL)、皮下液(75mg / 0.5mL)

LP Informationが発行した調査報告書(LPI21MY9606)
◆英語タイトル:Global Omalizumab for Injection Market Growth 2021-2026
◆商品コード:LPI21MY9606
◆発行会社(リサーチ会社):LP Information
◆発行日:2021年5月(※2024年版があります。お問い合わせください)
◆ページ数:132
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Information社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。LP Information社の概要及び新刊レポートはこちらでご確認いただけます。

LPインフォメーション社の「注射用オマリズマブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、注射用皮下粉末、皮下液(150mg / mL)、皮下液(75mg / 0.5mL)など、用途別には、病院、診療所などにセグメント区分してまとめました。注射用オマリズマブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・注射用オマリズマブの世界市場概要(サマリー)
・注射用オマリズマブの企業別販売量・売上
・注射用オマリズマブの企業別市場シェア
・注射用オマリズマブの世界市場規模 2016年-2021年:種類別(注射用皮下粉末、皮下液(150mg / mL)、皮下液(75mg / 0.5mL))
・注射用オマリズマブの世界市場規模 2016年-2021年:用途別(病院、診療所)
・注射用オマリズマブの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・注射用オマリズマブのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・注射用オマリズマブのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・注射用オマリズマブの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・注射用オマリズマブ市場の成長要因・課題・動向
・注射用オマリズマブの世界市場予測 2021年-2026年
・注射用オマリズマブの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・注射用オマリズマブのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・注射用オマリズマブのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・注射用オマリズマブの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・注射用オマリズマブの世界市場予測:種類別(注射用皮下粉末、皮下液(150mg / mL)、皮下液(75mg / 0.5mL))
・注射用オマリズマブの世界市場予測:用途別(病院、診療所)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Omalizumab for Injection will have significant change from previous year. By the most conservative estimates of global Omalizumab for Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Omalizumab for Injection market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Omalizumab for Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Subcutaneous Powder For Injection
Subcutaneous Solution (150 mg/mL)
Subcutaneous Solution(75 mg/0.5 mL)

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Hospital
Clinic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Roche
Novartis

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Omalizumab for Injection Consumption 2016-2026
2.1.2 Omalizumab for Injection Consumption CAGR by Region
2.2 Omalizumab for Injection Segment by Type
2.2.1 Subcutaneous Powder For Injection
2.2.2 Subcutaneous Solution (150 mg/mL)
2.2.3 Subcutaneous Solution(75 mg/0.5 mL)
2.3 Omalizumab for Injection Sales by Type
2.3.1 Global Omalizumab for Injection Sales Market Share by Type (2016-2021)
2.3.2 Global Omalizumab for Injection Revenue and Market Share by Type (2016-2021)
2.3.3 Global Omalizumab for Injection Sale Price by Type (2016-2021)
2.4 Omalizumab for Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Omalizumab for Injection Sales by Application
2.5.1 Global Omalizumab for Injection Sale Market Share by Application (2016-2021)
2.5.2 Global Omalizumab for Injection Revenue and Market Share by Application (2016-2021)
2.5.3 Global Omalizumab for Injection Sale Price by Application (2016-2021)

3 Global Omalizumab for Injection by Company
3.1 Global Omalizumab for Injection Sales Market Share by Company
3.1.1 Global Omalizumab for Injection Sales by Company (2019-2021)
3.1.2 Global Omalizumab for Injection Sales Market Share by Company (2019-2021)
3.2 Global Omalizumab for Injection Revenue Market Share by Company
3.2.1 Global Omalizumab for Injection Revenue by Company (2019-2021)
3.2.2 Global Omalizumab for Injection Revenue Market Share by Company (2019-2021)
3.3 Global Omalizumab for Injection Sale Price by Company
3.4 Global Manufacturers Omalizumab for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Omalizumab for Injection Product Location Distribution
3.4.2 Players Omalizumab for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Omalizumab for Injection by Region
4.1 Global Omalizumab for Injection by Region
4.1.1 Global Omalizumab for Injection Sales by Region
4.1.2 Global Omalizumab for Injection Revenue by Region
4.2 Americas Omalizumab for Injection Sales Growth
4.3 APAC Omalizumab for Injection Sales Growth
4.4 Europe Omalizumab for Injection Sales Growth
4.5 Middle East & Africa Omalizumab for Injection Sales Growth

5 Americas
5.1 Americas Omalizumab for Injection Sales by Country
5.1.1 Americas Omalizumab for Injection Sales by Country (2016-2021)
5.1.2 Americas Omalizumab for Injection Revenue by Country (2016-2021)
5.2 Americas Omalizumab for Injection Sales by Type
5.3 Americas Omalizumab for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Omalizumab for Injection Sales by Region
6.1.1 APAC Omalizumab for Injection Sales by Region (2016-2021)
6.1.2 APAC Omalizumab for Injection Revenue by Region (2016-2021)
6.2 APAC Omalizumab for Injection Sales by Type
6.3 APAC Omalizumab for Injection Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Omalizumab for Injection by Country
7.1.1 Europe Omalizumab for Injection Sales by Country (2016-2021)
7.1.2 Europe Omalizumab for Injection Revenue by Country (2016-2021)
7.2 Europe Omalizumab for Injection Sales by Type
7.3 Europe Omalizumab for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Omalizumab for Injection by Country
8.1.1 Middle East & Africa Omalizumab for Injection Sales by Country (2016-2021)
8.1.2 Middle East & Africa Omalizumab for Injection Revenue by Country (2016-2021)
8.2 Middle East & Africa Omalizumab for Injection Sales by Type
8.3 Middle East & Africa Omalizumab for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Omalizumab for Injection Distributors
10.3 Omalizumab for Injection Customer

11 Global Omalizumab for Injection Market Forecast
11.1 Global Omalizumab for Injection Forecast by Region
11.1.1 Global Omalizumab for Injection Forecast by Regions (2021-2026)
11.2.2 Global Omalizumab for Injection Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Omalizumab for Injection Forecast by Type
11.7 Global Omalizumab for Injection Forecast by Application

12 Key Players Analysis
12.1 Roche
12.1.1 Roche Roche Company Information
12.1.2 Roche Omalizumab for Injection Product Offered
12.1.3 Roche Omalizumab for Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Roche Main Business Overview
12.1.5 Roche Latest Developments
12.2 Novartis
12.2.1 Novartis Company Information
12.2.2 Novartis Omalizumab for Injection Product Offered
12.2.3 Novartis Omalizumab for Injection Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Novartis Main Business Overview
12.2.5 Novartis Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Omalizumab for Injection Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Subcutaneous Powder For Injection
Table 3. Major Players of Subcutaneous Solution (150 mg/mL)
Table 4. Major Players of Subcutaneous Solution(75 mg/0.5 mL)
Table 5. Global Omalizumab for Injection Sales by Type (2016-2021) & (K Units)
Table 6. Global Omalizumab for Injection Sales Market Share by Type (2016-2021)
Table 7. Global Omalizumab for Injection Revenue by Type (2016-2021) & ($ million)
Table 8. Global Omalizumab for Injection Revenue Market Share by Type (2016-2021)
Table 9. Global Omalizumab for Injection Sale Price by Type (2016-2021)
Table 10. Global Omalizumab for Injection Sales by Application (2016-2021) & (K Units)
Table 11. Global Omalizumab for Injection Sales Market Share by Application (2016-2021)
Table 12. Global Omalizumab for Injection Value by Application (2016-2021)
Table 13. Global Omalizumab for Injection Revenue Market Share by Application (2016-2021)
Table 14. Global Omalizumab for Injection Sale Price by Application (2016-2021)
Table 15. Global Omalizumab for Injection Sales by Company (2019-2021) & (K Units)
Table 16. Global Omalizumab for Injection Sales Market Share by Company (2019-2021)
Table 17. Global Omalizumab for Injection Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Omalizumab for Injection Revenue Market Share by Company (2019-2021)
Table 19. Global Omalizumab for Injection Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Omalizumab for Injection Producing Area Distribution and Sales Area
Table 21. Players Omalizumab for Injection Products Offered
Table 22. Omalizumab for Injection Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Omalizumab for Injection Sales by Region (2016-2021) (K Units)
Table 26. Global Omalizumab for Injection Sales Market Share by Region (2016-2021)
Table 27. Global Omalizumab for Injection Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Omalizumab for Injection Revenue Market Share by Region (2016-2021)
Table 29. Americas Omalizumab for Injection Sales by Country (2016-2021) & (K Units)
Table 30. Americas Omalizumab for Injection Sales Market Share by Country (2016-2021)
Table 31. Americas Omalizumab for Injection Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Omalizumab for Injection Revenue Market Share by Country (2016-2021)
Table 33. Americas Omalizumab for Injection Sales by Type (2016-2021) & (K Units)
Table 34. Americas Omalizumab for Injection Sales Market Share by Type (2016-2021)
Table 35. Americas Omalizumab for Injection Sales by Application (2016-2021) & (K Units)
Table 36. Americas Omalizumab for Injection Sales Market Share by Application (2016-2021)
Table 37. APAC Omalizumab for Injection Sales by Region (2016-2021) & (K Units)
Table 38. APAC Omalizumab for Injection Sales Market Share by Region (2016-2021)
Table 39. APAC Omalizumab for Injection Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Omalizumab for Injection Revenue Market Share by Region (2016-2021)
Table 41. APAC Omalizumab for Injection Sales by Type (2016-2021) & (K Units)
Table 42. APAC Omalizumab for Injection Sales Market Share by Type (2016-2021)
Table 43. APAC Omalizumab for Injection Sales by Application (2016-2021) & (K Units)
Table 44. APAC Omalizumab for Injection Sales Market Share by Application (2016-2021)
Table 45. Europe Omalizumab for Injection Sales by Country (2016-2021) & (K Units)
Table 46. Europe Omalizumab for Injection Sales Market Share by Country (2016-2021)
Table 47. Europe Omalizumab for Injection Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Omalizumab for Injection Revenue Market Share by Country (2016-2021)
Table 49. Europe Omalizumab for Injection Sales by Type (2016-2021) & (K Units)
Table 50. Europe Omalizumab for Injection Sales Market Share by Type (2016-2021)
Table 51. Europe Omalizumab for Injection Sales by Application (2016-2021) & (K Units)
Table 52. Europe Omalizumab for Injection Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Omalizumab for Injection Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Omalizumab for Injection Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Omalizumab for Injection Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Omalizumab for Injection Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Omalizumab for Injection Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Omalizumab for Injection Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Omalizumab for Injection Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Omalizumab for Injection Sales Market Share by Application (2016-2021)
Table 61. Global Omalizumab for Injection Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Omalizumab for Injection Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Omalizumab for Injection Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Omalizumab for Injection Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Omalizumab for Injection Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Omalizumab for Injection Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Omalizumab for Injection Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Omalizumab for Injection Revenue Market Share Forecast by Application (2021-2026)
Table 69. Roche Basic Information, Omalizumab for Injection Manufacturing Base, Sales Area and Its Competitors
Table 70. Roche Omalizumab for Injection Product Offered
Table 71. Roche Omalizumab for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 72. Roche Main Business
Table 73. Roche Latest Developments
Table 74. Novartis Basic Information, Omalizumab for Injection Manufacturing Base, Sales Area and Its Competitors
Table 75. Novartis Omalizumab for Injection Product Offered
Table 76. Novartis Omalizumab for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 77. Novartis Main Business
Table 78. Novartis Latest Developments
List of Figures
Figure 1. Picture of Omalizumab for Injection
Figure 2. Omalizumab for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Omalizumab for Injection Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Omalizumab for Injection Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Omalizumab for Injection Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Subcutaneous Powder For Injection
Figure 10. Product Picture of Subcutaneous Solution (150 mg/mL)
Figure 11. Product Picture of Subcutaneous Solution(75 mg/0.5 mL)
Figure 12. Global Omalizumab for Injection Sales Market Share by Type in 2020
Figure 13. Global Omalizumab for Injection Revenue Market Share by Type (2016-2021)
Figure 14. Omalizumab for Injection Consumed in Hospital
Figure 15. Global Omalizumab for Injection Market: Hospital (2016-2021) & (K Units)
Figure 16. Omalizumab for Injection Consumed in Clinic
Figure 17. Global Omalizumab for Injection Market: Clinic (2016-2021) & (K Units)
Figure 18. Global Omalizumab for Injection Sales Market Share by Application (2016-2021)
Figure 19. Global Omalizumab for Injection Revenue Market Share by Application in 2020
Figure 20. Global Omalizumab for Injection Revenue Market by Company in 2020 ($ Million)
Figure 21. Global Omalizumab for Injection Revenue Market Share by Company in 2020
Figure 22. Global Omalizumab for Injection Sales Market Share by Regions (2016-2021)
Figure 23. Global Omalizumab for Injection Revenue Market Share by Region in 2020
Figure 24. Americas Omalizumab for Injection Sales 2016-2021 (K Units)
Figure 25. Americas Omalizumab for Injection Revenue 2016-2021 ($ Millions)
Figure 26. APAC Omalizumab for Injection Sales 2016-2021 (K Units)
Figure 27. APAC Omalizumab for Injection Revenue 2016-2021 ($ Millions)
Figure 28. Europe Omalizumab for Injection Sales 2016-2021 (K Units)
Figure 29. Europe Omalizumab for Injection Revenue 2016-2021 ($ Millions)
Figure 30. Middle East & Africa Omalizumab for Injection Sales 2016-2021 (K Units)
Figure 31. Middle East & Africa Omalizumab for Injection Revenue 2016-2021 ($ Millions)
Figure 32. Americas Omalizumab for Injection Sales Market Share by Country in 2020
Figure 33. Americas Omalizumab for Injection Revenue Market Share by Country in 2020
Figure 34. Americas Omalizumab for Injection Sales Market Share by Type in 2020
Figure 35. Americas Omalizumab for Injection Sales Market Share by Application in 2020
Figure 36. United States Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 37. Canada Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 38. Mexico Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 39. Brazil Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 40. APAC Omalizumab for Injection Sales Market Share by Region in 2020
Figure 41. APAC Omalizumab for Injection Revenue Market Share by Regions in 2020
Figure 42. APAC Omalizumab for Injection Sales Market Share by Type in 2020
Figure 43. APAC Omalizumab for Injection Sales Market Share by Application in 2020
Figure 44. China Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 45. Japan Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 46. Korea Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 47. Southeast Asia Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 48. India Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 49. Australia Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 50. Europe Omalizumab for Injection Sales Market Share by Country in 2020
Figure 51. Europe Omalizumab for Injection Revenue Market Share by Country in 2020
Figure 52. Europe Omalizumab for Injection Sales Market Share by Type in 2020
Figure 53. Europe Omalizumab for Injection Sales Market Share by Application in 2020
Figure 54. Germany Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 55. France Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 56. UK Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 57. Italy Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 58. Russia Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 59. Middle East & Africa Omalizumab for Injection Sales Market Share by Country in 2020
Figure 60. Middle East & Africa Omalizumab for Injection Revenue Market Share by Country in 2020
Figure 61. Middle East & Africa Omalizumab for Injection Sales Market Share by Type in 2020
Figure 62. Middle East & Africa Omalizumab for Injection Sales Market Share by Application in 2020
Figure 63. Egypt Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 64. South Africa Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 65. Israel Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 66. Turkey Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 67. GCC Country Omalizumab for Injection Revenue Growth 2016-2021 ($ Millions)
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles


【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の注射用オマリズマブ市場2021-2026:注射用皮下粉末、皮下液(150mg / mL)、皮下液(75mg / 0.5mL)(Global Omalizumab for Injection Market Growth 2021-2026)]についてメールでお問い合わせはこちらでお願いします。